Enbrel



Combined with:

Asa

Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 51.1%
Psoriasis 17.8%
Psoriatic Arthropathy 12.6%
Product Used For Unknown Indication 6.7%
Ankylosing Spondylitis 4.9%
Drug Use For Unknown Indication 1.9%
Juvenile Arthritis 1.5%
Hypertension 0.7%
Pain 0.4%
Osteoporosis 0.4%
Arthritis 0.3%
Juvenile Idiopathic Arthritis 0.3%
Prophylaxis 0.3%
Osteoarthritis 0.2%
Diabetes Mellitus 0.2%
Systemic Lupus Erythematosus 0.2%
Polyarthritis 0.2%
Depression 0.1%
Spondyloarthropathy 0.1%
Fibromyalgia 0.1%
Injection Site Pain 19.1%
Psoriasis 9.8%
Rheumatoid Arthritis 8.6%
Injection Site Swelling 6.7%
Drug Ineffective 5.4%
Pain In Extremity 5.1%
Injection Site Reaction 5.0%
Sinusitis 4.8%
Injection Site Warmth 4.3%
Injection Site Erythema 4.1%
Nasopharyngitis 3.9%
Pain 3.3%
Therapeutic Response Decreased 3.2%
Injection Site Pruritus 3.0%
Headache 2.5%
Injection Site Haematoma 2.5%
Vomiting 2.2%
Arthralgia 2.2%
Pyrexia 2.1%
Nausea 2.1%
Secondary
Rheumatoid Arthritis 28.7%
Psoriasis 25.3%
Psoriatic Arthropathy 24.2%
Product Used For Unknown Indication 4.8%
Ankylosing Spondylitis 4.4%
Drug Use For Unknown Indication 2.1%
Hypertension 1.6%
Osteoarthritis 1.3%
Juvenile Arthritis 1.2%
Osteoporosis 1.2%
Pain 0.8%
Systemic Lupus Erythematosus 0.7%
Prophylaxis 0.7%
Arthritis 0.7%
Fibromyalgia 0.7%
Sjogren's Syndrome 0.4%
Diabetes Mellitus 0.4%
Gastritis 0.3%
Antibiotic Prophylaxis 0.3%
Depression 0.3%
Psoriasis 23.4%
Injection Site Pain 13.7%
Psoriatic Arthropathy 8.9%
Rheumatoid Arthritis 6.4%
Drug Ineffective 5.4%
Pain In Extremity 4.1%
Therapeutic Response Decreased 3.9%
Injection Site Swelling 3.5%
Sinusitis 3.4%
Injection Site Warmth 3.0%
Pain 2.9%
Vomiting 2.7%
Injection Site Erythema 2.6%
Injection Site Reaction 2.6%
Urinary Tract Infection 2.5%
Nasopharyngitis 2.3%
Arthralgia 2.3%
Weight Decreased 2.2%
Weight Increased 2.1%
Pyrexia 2.1%
Concomitant
Rheumatoid Arthritis 28.2%
Product Used For Unknown Indication 24.2%
Drug Use For Unknown Indication 9.1%
Osteoporosis 6.9%
Psoriasis 6.6%
Hypertension 4.2%
Psoriatic Arthropathy 3.6%
Pain 2.9%
Depression 2.2%
Arthritis 1.8%
Diabetes Mellitus 1.4%
Ankylosing Spondylitis 1.3%
Prophylaxis 1.2%
Blood Cholesterol Increased 1.0%
Hypothyroidism 1.0%
Osteopenia 0.9%
Asthma 0.9%
Anxiety 0.9%
Arthralgia 0.8%
Systemic Lupus Erythematosus 0.8%
Weight Decreased 10.1%
Drug Ineffective 9.0%
Rheumatoid Arthritis 9.0%
Vomiting 6.3%
Nausea 5.9%
Psoriasis 5.9%
Urticaria 5.5%
Myocardial Infarction 5.3%
Weight Increased 5.0%
Wound Infection Staphylococcal 4.8%
Urinary Tract Infection 4.2%
Rash 3.7%
Vision Blurred 3.7%
Death 3.5%
Vertigo 3.5%
Pain 3.3%
Fatigue 3.1%
Pneumonia 2.8%
Sinusitis 2.8%
Dyspnoea 2.6%
Interacting
Rheumatoid Arthritis 26.4%
Drug Use For Unknown Indication 8.5%
Epilepsy 8.5%
Product Used For Unknown Indication 8.5%
Psoriasis 8.5%
Factor Viii Deficiency 7.8%
Furuncle 7.0%
Psoriatic Arthropathy 6.2%
Hypertension 3.9%
Atrial Fibrillation 3.1%
Arthralgia 1.6%
Arthritis 1.6%
Cardioversion 1.6%
Depression 1.6%
Tuberculosis Skin Test Positive 1.6%
Ankylosing Spondylitis 0.8%
Bronchitis 0.8%
Cerebrovascular Accident Prophylaxis 0.8%
Contraception 0.8%
Lower Respiratory Tract Infection 0.8%
Kidney Infection 9.5%
Abdominal Pain 7.1%
Headache 7.1%
Malaise 7.1%
Rheumatoid Arthritis 7.1%
Vasculitis 7.1%
Blood Alkaline Phosphatase Increased 4.8%
Drug Interaction 4.8%
Furuncle 4.8%
Hepatic Enzyme Increased 4.8%
Pain 4.8%
Transaminases Increased 4.8%
Viiith Nerve Lesion 4.8%
Visual Impairment 4.8%
White Blood Cell Count Decreased 4.8%
Aplasia Pure Red Cell 2.4%
Asthenia 2.4%
Colitis 2.4%
Dyspnoea 2.4%
Epilepsy 2.4%